PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.81%
Positive revenue growth while MCHP is negative. John Neff might see a notable competitive edge here.
3.64%
Gross profit growth under 50% of MCHP's 13.10%. Michael Burry would be concerned about a severe competitive disadvantage.
4.17%
EBIT growth below 50% of MCHP's 94.15%. Michael Burry would suspect deeper competitive or cost structure issues.
5.51%
Operating income growth under 50% of MCHP's 89.58%. Michael Burry would be concerned about deeper cost or sales issues.
9.20%
Positive net income growth while MCHP is negative. John Neff might see a big relative performance advantage.
10.14%
Positive EPS growth while MCHP is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
9.56%
Positive diluted EPS growth while MCHP is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.21%
Share reduction while MCHP is at 0.38%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.08%
Dividend growth under 50% of MCHP's 0.20%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
10.91%
Positive OCF growth while MCHP is negative. John Neff would see this as a clear operational advantage vs. the competitor.
21.89%
FCF growth above 1.5x MCHP's 9.29%. David Dodd would verify if the firm’s strategic investments yield superior returns.
75.75%
10Y revenue/share CAGR under 50% of MCHP's 449.94%. Michael Burry would suspect a lasting competitive disadvantage.
22.11%
5Y revenue/share CAGR under 50% of MCHP's 139.31%. Michael Burry would suspect a significant competitive gap or product weakness.
9.87%
3Y revenue/share CAGR under 50% of MCHP's 118.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
220.59%
10Y OCF/share CAGR under 50% of MCHP's 12780.81%. Michael Burry would worry about a persistent underperformance in cash creation.
63.29%
Below 50% of MCHP's 172.64%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
50.95%
3Y OCF/share CAGR at 50-75% of MCHP's 96.48%. Martin Whitman would suspect weaker recent execution or product competitiveness.
255.52%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
95.58%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
57.62%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
27.78%
Below 50% of MCHP's 289.54%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.72%
Negative 5Y equity/share growth while MCHP is at 108.85%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.47%
Negative 3Y equity/share growth while MCHP is at 108.47%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
601.27%
10Y dividend/share CAGR above 1.5x MCHP's 7.67%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
156.24%
5Y dividend/share CAGR above 1.5x MCHP's 2.83%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
102.09%
3Y dividend/share CAGR above 1.5x MCHP's 1.76%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-5.43%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.88%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.50%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.11%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-0.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.82%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.